The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant

Human Immunology

Volumn 63, Issue 10, 2002, Pages 912-925

  Illigens, Ben M ^a   Yamada, Akira ^b   Fedoseyeva, Eugenia V ^a   Anosova, Natalie ^a   Boisgerault, Florence ^a   Valujskikh, Anna ^c   Heeger, Peter S ^c   Sayegh, Mohamed H ^b   Boehm, Bernhard ^d   Benichou, Gilles ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Allorecognition; Direct indirect pathways; Graft rejection; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORNEA TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETINA SURGERY; SKIN TRANSPLANTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CORNEAL TRANSPLANTATION; GRAFT REJECTION; INTERFERON TYPE II; INTERLEUKIN-2; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036776218     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00449-4     Document Type: Article

References (75)

1. Hayry P: Molecular pathology of acute and chronic rejection. Transplant Proc 26:3280, 1994.
2. Krensky AM, Clayberger C: The nature of allorecognition. Curr Opin Nephrol Hypertens 2:898, 1993.
3. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 10:333, 1992.
4. Warrens AN, Lombardi G, Lechler RI: Presentation and recognition of major and minor histocompatibility antigens. Transpl Immunol 2:103, 1994.
5. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH: The molecular basis of alloreactivity. Immunol Today 11:83, 1990.
6. Lechler R, Lombardi G: Structural aspects of allorecognition. Curr Opin Immunol 3:715, 1991.
7. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A: Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 165:1296, 1987.
8. Fedoseyeva EV, Tam RC, Popov IA, Orr PL, Garovoy MR, Benichou G: Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 61:679, 1996.
9. Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G: De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162:6836, 1999.
10. Mares DC, Heidler KM, Smith GN, Cummings OW, Harris ER, Foresman B, Wilkes DS: Type V collagen modulates alloantigen-induced pathology and immunology in the lung. Am J Respir Cell Mol Biol 23:62, 2000.
11. Rolls HK, Kishimoto K, Illigens BM, Dong V, Sayegh MH, Benichou G, Fedoseyeva EV: Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection. Transplant Proc 33:3821, 2001.
12. Yasufuku K, Heidler KM, O'Donnell PW, Smith Jr. GN, Cummings OW, Foresman BH, Fujisawa T, Wilkes DS: Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 25:26, 2001.
13. Yasufuku K, Heidler KM, Woods KA, Smith Jr. GN, Cummings OW, Fujisawa T, Wilkes DS: Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73:500, 2002.
14. Ashwell JD, Chen C, Schwartz RH: High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol 136:389, 1986.
15. Lechler RI, Batchelor JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31, 1982.
16. Lechler R, Batchelor R, Lombardi G: The relationship between MHC restricted and allospecific T cell recognition. Immunol Lett 29:41, 1991.
17. Lechler RI, Heaton T, Barber L, Bal V, Batchelor JR, Lombardi G: Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett 34:63, 1992.
18. Lombardi G, Barber L, Aichinger G, Heaton T, Sidhu S, Batchelor JR, Lechler RI: Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules. Influence of the beta 2-domain correlates with CD4 dependence. J Immunol 147:2034, 1991.
19. Lombardi G, Lechler R: The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes. Ann Ist Super Sanita 27:7, 1991.
20. Matzinger P, Bevan MJ: Hypothesis: Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 29:1, 1977.
21. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA: Quaritifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 166:973, 2001.
22. Auchincloss H, Jr., Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH: The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 90:3373, 1993.
23. Benham AM, Sawyer GJ, Fabre JW: Indirect T cell allorecognition of dono antigens contributes to the rejection of vascularized kidney allografts. Transplantation 59:1028, 1995.
24. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 175:305, 1992.
25. Benichou G, Fedoseyeva E, Lehmann PV, Olson CA, Geysen HM, McMillan M, Sercarz EE: Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J Immunol 153:938, 1994.
26. Benichou G, Tam RC, Soares LR, Popov IA, Garovoy MR, Fedoseyeva EV: The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance. Res Immunol 147:377, 1996.
27. Benichou G, Tam RC, Soares LR, Fedoseyeva EV: Indirect T-cell allorecognition: Perspectives for peptide-based therapy in transplantation. Immunol Today 18:67, 1997.
28. Fangmann J, Dalchau R, Fabre JW: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 175:1521, 1992.
29. Liu Z, Braunstein NS, Suciu-Foca N: T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 148:35, 1992.
30. Liu Z, Colovai AI, Tugulea S, Reed EF, Fisher PE, Mancini D, Rose EA, Cortesini R, Michler RE, Suciu-Foca N: Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 98:1150, 1996.
31. Liu Z, Colovai AI, Tugulea S, Reed EF, Harris PE, Maffei A, Molajoni ER, Gargano F, Cortesini R, Hardy MA, Suciu-Foca N: Mapping of dominant HLA-DR determinants recognized via the indirect pathway. Transplant Proc 29:1014, 1997.
32. Sayegh MH, Carpenter CB: Role of indirect allorecognition in allograft rejection. Int Rev Immunol 13:221, 1996.
33. Valujskikh A, Feoseyeva EV, Benichou G, Heeger PS: Development of pathogenic autoimmunity following graft rejection via an indirect alloresponse. Transplantation 73:1130, 2002.
34. Benichou G, Valujskikh A, Heeger PS: Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 162:352, 1999.
35. Benichou G: Direct and indirect antigen recognition: The pathways to allograft immune rejection. Front Biosci 4:D476, 1999.
36. Bradley JA: Indirect T cell recognition in allograft rejection. Int Rev Immunol 13:245, 1996.
37. Fangmann J, Dalchau R, Fabre JW: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. Transplant Proc 25:183, 1993.
38. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss Jr. H: Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 179:865, 1994.
39. Liu Z, Sun YK, Xi XYP, Maffei A, Reed E, Harris P, Suciu-Foca N: Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 177:1643, 1993.
40. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G: Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 56:461, 1993.
41. Sayegh MH, Perico N, Gallon L, Imberti O, Hancock WW, Remuzzi G, Carpenter CB: Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 58:125, 1994.
42. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB: Mechanisms of oral tolerance by MHC peptides. Ann NY Acad Sci 778:338, 1996.
43. Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in transplantation. Immunol Today 15:32, 1994.
44. Suciu-Foca N, Liu Z, Harris PE, Reed EF, Cohen DJ, Benstein JA, Benvenisty AI, Mancini D, Michler RE, Rose EA, et al: Indirect recognition of native HLA alloantigens and B-cell help. Transplant Proc 27:455, 1995.
45. Suciu-Foca N, Liu Z, Colovai AI, Tugulea S, Reed EF, Mancini D, Cohen DJ, Benvenisty AI, Benstein JA, Hardy MA, Schulman LL, Rose EA: Role of indirect allorecognition in chronic rejection of human allografts. Transplant Proc 28:404, 1996.
46. Suciu-Foca N, Liu Z, Colovai AI, Fisher P, Ho HE, Reed EF, Rose EA, Michler RE, Hardy MA, Cocciolo P, Gargano F, Cortesini R: Indirect T-cell recognition in human allograft rejection. Transplant Proc 29:1012, 1997.
47. Valujskikh A, Matesic D, Gilliam A, Anthony D, Haqqi TM, Heeger PS: T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 101:1398, 1998.
48. Valujskikh A, Matesic D, Heeger PS: Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. Transplantation 68:1029, 1999.
49. Valujskikh A, Heeger PS: CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferon-gamma. Transplantation 69:1016, 2000.
50. Billingham RE, Medawar PD: The technique of free skin grafting in mammals. J Exp Biol 28:385, 1951.
51. Matesic D, Lehmann PV, Heeger PS: High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 65:906, 1998.
52. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW: Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 158:1572, 1997.
53. Sonoda Y, Streilein JW: Orthotopic corneal transplantation in mice - Evidence that the immunogenetic rules of rejection do not apply. Transplantation 54:694, 1992.
54. Sonoda Y, Streilein JW: Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol 150:1727, 1993.
55. Sonoda Y, Sano Y, Ksander B, Streilein JW: Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 36:427, 1995.
56. Niederkorn JY: The immunology of corneal transplantation. Dev Ophthalmol 30:129, 1999.
57. Whitsett CF, Stulting RD: The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci 25:519, 1984.
58. Sano Y, Ksander BR, Streilein JW: Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transpl Immunol 4:53, 1996.
59. Sano Y, Ksander BR, Streilein JW: Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 38:1130, 1997.
60. Boisgerault F, Liu Y, Anosova N, Ehrlich E, Dana MR, Benichou G: Role of CD4(+) and CD8(+) t cells in allorecognition: Lessons from corneal transplantation. J Immunol 167:1891, 2001.
61. He YG, Ross J, Niederkorn JY: Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 32:2723, 1991.
62. Yamada J, Kurimoto I, Streilein JW: Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 40:2614, 1999.
63. Larkin DF, Calder VL, Lightman SL: Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol 107:381, 1997.
64. Joo CK, Pepose JS, Stuart PM: T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 36:1530, 1995.
65. Ksander BR, Sano Y, Streilein JW: Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl Immunol 4:49, 1996.
66. Peeler J, Niederkorn J, Matoba A: Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice. Invest Ophthalmol Vis Sci 26:1516, 1985.
67. Streilein JW: Regional immunity and ocular immune privilege. Chem Immunol 73:11, 1999.
68. Streilein JW: Immunologic privilege of the eye. Springer Semin Immunopathol 21:95, 1999.
69. Anosova NG, Illigens B, Boisgerault F, Fedoseyeva EV, Young MJ, Benichou G: Antigenicity and immunogenicity of allogeneic retinal transplants. J Clin Invest 108:1175, 2001.
70. Jiang LQ, Streilein JW: Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally. Transplantation 52:513, 1991.
71. Jiang LQ, del Cerro M: Reciprocal retinal transplantation: A tool for the study of an inherited retinal degeneration. Exp Neurol 115:325, 1992.
72. Jiang LQ, Jorquera M, Streilein JW: Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 34:3347, 1993.
73. Jiang LQ, Jorquera M, Streilein JW: Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts. Exp Eye Res 58:719, 1994.
74. Jiang LQ, Jorquera M, Streilein JW, Ishioka M: Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye. Transplantation 59:1201, 1995.
75. Lombardi G, Sidhu S, Batchelor JR, Lechler RI: Allorecognition of DR1 by T cells from a DR4/DRwl3 responder mimics self-restricted recognition of endogenous peptides [published erratum appears in Proc Natl Acad Sci USA 86:10074, 1989]. Proc Natl Acad Sci USA 86:4190, 1989.